D’orazio Associates Lowers stake in HCP (HCP)

HCP (HCP) : D’orazio Associates reduced its stake in HCP by 67.42% during the most recent quarter end. The investment management company now holds a total of 24,101 shares of HCP which is valued at $708,569 after selling 49,883 shares in HCP , the firm said in a disclosure report filed with the SEC on Nov 14, 2016.HCP makes up approximately 0.26% of D’orazio Associates’s portfolio.

Other Hedge Funds, Including , Putnam Investments boosted its stake in HCP in the latest quarter, The investment management firm added 155,002 additional shares and now holds a total of 191,356 shares of HCP which is valued at $5,625,866. HCP makes up approx 0.01% of Putnam Investments’s portfolio.Stephens Inc Ar reduced its stake in HCP by selling 7,563 shares or 15.18% in the most recent quarter. The Hedge Fund company now holds 42,257 shares of HCP which is valued at $1,180,661. HCP makes up approx 0.05% of Stephens Inc Ar’s portfolio.Advisor Group boosted its stake in HCP in the latest quarter, The investment management firm added 6,305 additional shares and now holds a total of 80,658 shares of HCP which is valued at $2,325,370. HCP makes up approx 0.06% of Advisor Group’s portfolio. Old Mutual Global Investors (uk) Ltd. added HCP to its portfolio by purchasing 19,966 company shares during the most recent quarter which is valued at $683,836. HCP makes up approx 0.01% of Old Mutual Global Investors (uk) Ltd.’s portfolio.Concert Wealth Management boosted its stake in HCP in the latest quarter, The investment management firm added 7,101 additional shares and now holds a total of 80,131 shares of HCP which is valued at $2,735,672. HCP makes up approx 0.34% of Concert Wealth Management’s portfolio.

HCP closed down -0.08 points or -0.28% at $28.68 with 30,52,653 shares getting traded on Monday. Post opening the session at $28.78, the shares hit an intraday low of $28.48 and an intraday high of $28.94 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, HCP reported $0.72 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Nov 1, 2016. Analyst had a consensus of $0.71.Analysts expectations of $ 626.34.During the same quarter in the previous year, the company posted $0.79 EPS.

Many Wall Street Analysts have commented on HCP. Mizuho Upgraded HCP on Nov 21, 2016 to ” Buy”, Price Target of the shares are set at $32.Shares were Upgraded by RBC Capital Mkts on Nov 4, 2016 to ” Sector Perform” and Lowered the Price Target to $ 30 from a previous price target of $35 .Shares were Reiterated by Mizuho on Nov 2, 2016 to “Neutral” and Lowered the Price Target to $ 31 from a previous price target of $37 .

HCP Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing post-acute/skilled nursing life science medical office and hospital. Its portfolio includes owned portfolio unconsolidated joint ventures and developments and redevelopments. Its owned portfolio includes around 1040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing life science and medical office segments. It has assets under development redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments which are under development or redevelopment include Pacific Corporate Park Memorial Hermann Sky Ridge Bayfront Folsom and Deer Park.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

HCP - Is it time to Sell?

Top Brokerage Firms are advising their investors on HCP. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.